Autoimmune diseases are not infrequently associated with arterial or venous thrombotic
events. Chronic inflammation and immune system impairment are considered the main …

Autoimmune diseases have specific pathophysiologic mechanisms leading to an increased
risk of arterial and venous thrombosis. The risk of venous thromboembolism (VTE) varies …

Venous thromboembolism (VTE) is major health problem and is sometimes complicated by
lethal pulmonary embolism (PE). Disturbances of the coagulation and anticoagulation …

Systemic autoimmune diseases are conditions of unknown etiology, characterized by the
simultaneous or successive involvement of most organs and systems, as well as the …

Patients with autoimmune disorders are at an increased risk of venous thromboembolism
(VTE), but this association has not been consistently evaluated. We used the RIETE …

Background: Systemic inflammation is associated with vessel wall damage, upregulation of
procoagulants, downregulation of anticoagulants, and suppression of fibrinolysis …

Despite an abundance of literature on the risk of a first venous thromboembolic event (VTE)
in autoimmune diseases, specific recommendations about managing VTE in autoimmune …

Glucocorticoids are potent anti-inflammatory agents that are widely used for the treatment of
many inflammatory, autoimmune, and neoplastic disorders. However, their beneficial effect …

Maintenance of normal blood flow requires equilibrium between procoagulant and
anticoagulant factors; occasionally, procoagulant activity predominates, leading to clot …

Background Some autoimmune disorders have been linked to venous thromboembolism.
We examined whether there is an association between autoimmune disorders and risk of …